Saturday, July 11, 2026

Drug profile · INN

pentetate zinc trisodium

pentetate zinc trisodium (PENTETATE ZINC TRISODIUM) is a radioactive metals chelating agent. Route of administration: inhalation, intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — pentetate zinc trisodium
US status
approved
Class
Route
INHALATION, INTRAVENOUS
Patents
0
Programs
0
Data quality
0.84

Quick answer

pentetate zinc trisodium (PENTETATE ZINC TRISODIUM) is a radioactive metals chelating agent. Route of administration: inhalation, intravenous. Current US regulatory status: approved.

Key facts

INN pentetate zinc trisodium
Brand PENTETATE ZINC TRISODIUM
Mechanism Radioactive metals chelating agent
Target Radioactive metals
Route INHALATION, INTRAVENOUS
Formulation SOLUTION

Mechanism of action

Radioactive metals chelating agent

Primary target: Radioactive metals

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. ferric hexacyanoferrate(ii) Radioactive metals chelating agent
  2. pentetate calcium trisodium Radioactive metals chelating agent
  3. pentetate calcium trisodium yb-169 Radioactive metals chelating agent

Frequently asked questions

What is pentetate zinc trisodium?

pentetate zinc trisodium (PENTETATE ZINC TRISODIUM) is a radioactive metals chelating agent. Route of administration: inhalation, intravenous. Current US regulatory status: approved.

What is the brand name for pentetate zinc trisodium?

PENTETATE ZINC TRISODIUM is a marketed brand name for pentetate zinc trisodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pentetate zinc trisodium?

pentetate zinc trisodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.